Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health | FMCG | Executive
         
Latest Jobs

Kent & Medway
23 May 2013 17:58



NORTH EAST FRANCE
23 May 2013 17:55



North London/Essex
23 May 2013 17:09


Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Joe Moore
Operations Director
joe@zenopa.com
+44 1494 818011

Testimonials
One of the frustrations from the candidate side is when communication stops and you do not know whether the role is still live or not.
Tony, 2011

Deaths from heart attacks 'halved'

2 May 2007 00:00 in Industry related health news


Advances in medical treatment have led to the number of deaths from severe heart attacks following admission to hospital nearly halving in the last six years, according to a new report published in the Journal of American Medical Association.

The international study led by researchers at the University of Edinburgh also found that there has been a decline in heart failure. Their findings are based on figures from hospital treatment and outcomes for 44,372 patients admitted to 113 hospitals in 14 countries with heart attacks or unstable angina.

In patients with a severe heart attack, death rates reduced from 8.4 to 4.5 per cent. Their risk of heart failure almost halved as well. This equates to 39 fewer deaths and 90 less patients with new heart failure for every 1,000 patients entering hospital.

Professor Keith Fox of Edinburgh University said that until now there has been a "substantial gap" in knowing how new drugs and procedures are able to affect hospital outcomes.

Advances which have contributed to the decline in heart attack deaths include the use of beta blockers, statins and anti-clotting agents, he claims.

"However, these long-term prevention methods do not account for improved outcomes while patients are in hospital, which must be down to the acute treatments given after admission.

"We have taken into account risk factors and the improved outcomes are not because patients are less unwell when they arrive at hospital," Professor Fox added.

Commenting on the study's findings, Professor Peter Weissberg, medical director at the British Heart Foundation (BHF), said: "This is a great example of why long-term investment in heart research is vital."

Other news stories from 02/05/2007

Recent news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Adfero News Agency



   
© Copyright 2013 Zenopa Ltd